PESUA18 | In vivo and in vitro evidence for infection of naïve CD4 T cells with CCR5-tropic HIV | Poster exhibition | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
PESUA19 | High prevalence of HIV persistence in CSF of adolescents and young adults with perinatally-acquired HIV and cognitive impairment in the IMPAACT 2015 study | Poster exhibition | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
PESUA20 | Subtype A1 and D HIV-1 proviral genome landscape in Rakai, Uganda | Poster exhibition | Identification, characterisation and Quantification of HIV/SIV reservoirs and rebounding virus |
PESUA21 | The LRA HODHBt synergizes with IL-15 to enhance the cytotoxic capacity of HIV-specific CTL | Poster exhibition | Strategies to reduce/eliminate viral reservoirs |
PESUA22 | Productively-infected CD4 T cells are resistant to ADCC mediated by non-neutralizing antibodies | Poster exhibition | Strategies to reduce/eliminate viral reservoirs |
PESUA23 | Longer intervals between SARS-CoV-2 infection and SpikeVax doses improve the neutralization of different variants of concern | Poster exhibition | Immune responses to SARS-Cov2 |
PESUA24 | Chronic CNS inflammation in ART-suppressed SIV-infected rhesus macaques is associated with immune activation and viral persistence in the gut | Poster exhibition | Neuropathogenesis |
PESUA25 | Unvaccinated individuals admitted to the ICU due to fatal COVID-19 showed progressive decay of unresponsive cytotoxic cells | Poster exhibition | Immune responses to SARS-Cov2 |
PESUB14 | Low frequency of activated T cells in people living with HIV, aviremic under treatment, and presenting neurocognitive disorders | Poster exhibition | Neurologic disorders (e.g. CNS malignancies) |
PESUB15 | Incidence of and risk factors for heart failure subtypes in women and men living with HIV | Poster exhibition | Cardiovascular disease |